Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 3-((2,3-cyclopenteno-1-pyridinium)methyl)-7-(2-syn-methoximino-2-(2-aminothiazole-4-yl)acetamido)ceph-3-em-4-carboxylate
2. Cefpirome Sulfate
3. Cefrom
4. Hr 810
5. Hr-810
6. Metran
1. 84957-29-9
2. Cefpiroma
3. Cefpiromum
4. Cefrom
5. Cefir
6. Cefpirome Sulfate
7. Hr 810
8. Hr-810 Free Base
9. Chebi:3503
10. S72q2f09hy
11. Hr-810
12. Cefpirome (inn)
13. (6r,7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(6,7-dihydro-5h-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
14. Cefpirome Sulphate
15. Cefpirome [inn]
16. (6r,7r)-7-{[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(6,7-dihydro-5h-cyclopenta[b]pyridinium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
17. 5h-cyclopenta[b]pyridinium,1-[[(6r,7r)-7-[[(2z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-6,7-dihydro-, Inner Salt
18. Cefpiromum [latin]
19. Cefpiroma [spanish]
20. Cefpirome [inn:ban]
21. Ncgc00181339-01
22. Unii-s72q2f09hy
23. Broact
24. Keiten
25. Keiten, Cefpiroma
26. Cefir (tn)
27. Cefpirome [mi]
28. Cefpirome [who-dd]
29. Schembl49406
30. Mls006010792
31. Chembl65794
32. Dtxsid2048244
33. Schembl22207951
34. Akos016013926
35. Db13682
36. 1-(((6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-6,7-dihydro-5h-1-pyridinium Hydroxide, Inner Salt
37. 5h-1-pyrindinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-6,7-dihydro-, Hydroxide, Inner Salt, (6r-(6alpha,7beta(z)))-
38. Smr004701476
39. 98753-19-6
40. D07649
41. (6r,7r)-7-((2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido)-8-oxo-3-(2beta-trimethylenpyridinio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carboxylat
42. 1-(((6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-6,7-dihydro-5h-1-pyrindinium Hydroxide, Inner Salt, 72-(z)-(o-methyloxime)
43. 1-{[(6r,7r)-2-carboxylato-7-{[(2z)-1-hydroxy-2-(2-imino-2,3-dihydro-1,3-thiazol-4-yl)-2-(methoxyimino)ethylidene]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}-5h,6h,7h-cyclopenta[b]pyridin-1-ium
44. 5h-1-pyrindinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-5,6,7,8-tetrahydro-, Hydroxide, Inner Salt, (6r-(6alpha,7beta(z)))-
45. 5h-1-pyrindinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-6,7-dihydro-, Hydroxide, Inner Salt, (6r-(6.alpha.,7.beta.(z)))-
46. 7-{[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(6,7-dihydro-5h-cyclopenta[b]pyridinium-1-ylmethyl)-3,4-didehydrocepham-4-carboxylic Acid
| Molecular Weight | 514.6 g/mol |
|---|---|
| Molecular Formula | C22H22N6O5S2 |
| XLogP3 | 0.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 6 |
| Exact Mass | 514.10931017 g/mol |
| Monoisotopic Mass | 514.10931017 g/mol |
| Topological Polar Surface Area | 208 Ų |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 955 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01D - Other beta-lactam antibacterials
J01DE - Fourth-generation cephalosporins
J01DE02 - Cefpirome
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
20
PharmaCompass offers a list of Cefpirome Sulphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cefpirome Sulphate manufacturer or Cefpirome Sulphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cefpirome Sulphate manufacturer or Cefpirome Sulphate supplier.
PharmaCompass also assists you with knowing the Cefpirome Sulphate API Price utilized in the formulation of products. Cefpirome Sulphate API Price is not always fixed or binding as the Cefpirome Sulphate Price is obtained through a variety of data sources. The Cefpirome Sulphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cefpiroma manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cefpiroma, including repackagers and relabelers. The FDA regulates Cefpiroma manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cefpiroma API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cefpiroma manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cefpiroma supplier is an individual or a company that provides Cefpiroma active pharmaceutical ingredient (API) or Cefpiroma finished formulations upon request. The Cefpiroma suppliers may include Cefpiroma API manufacturers, exporters, distributors and traders.
click here to find a list of Cefpiroma suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cefpiroma Drug Master File in Japan (Cefpiroma JDMF) empowers Cefpiroma API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cefpiroma JDMF during the approval evaluation for pharmaceutical products. At the time of Cefpiroma JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cefpiroma suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cefpiroma Drug Master File in Korea (Cefpiroma KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cefpiroma. The MFDS reviews the Cefpiroma KDMF as part of the drug registration process and uses the information provided in the Cefpiroma KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cefpiroma KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cefpiroma API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cefpiroma suppliers with KDMF on PharmaCompass.
A Cefpiroma written confirmation (Cefpiroma WC) is an official document issued by a regulatory agency to a Cefpiroma manufacturer, verifying that the manufacturing facility of a Cefpiroma active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cefpiroma APIs or Cefpiroma finished pharmaceutical products to another nation, regulatory agencies frequently require a Cefpiroma WC (written confirmation) as part of the regulatory process.
click here to find a list of Cefpiroma suppliers with Written Confirmation (WC) on PharmaCompass.
Cefpiroma Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cefpiroma GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cefpiroma GMP manufacturer or Cefpiroma GMP API supplier for your needs.
A Cefpiroma CoA (Certificate of Analysis) is a formal document that attests to Cefpiroma's compliance with Cefpiroma specifications and serves as a tool for batch-level quality control.
Cefpiroma CoA mostly includes findings from lab analyses of a specific batch. For each Cefpiroma CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cefpiroma may be tested according to a variety of international standards, such as European Pharmacopoeia (Cefpiroma EP), Cefpiroma JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cefpiroma USP).
